{"product_id":"mapk6-erk3-antibody-sc-f2109","title":"MAPK6\/ERK3 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eMAPK6\/ERK3 is a target of interest in many antibody-based workflows. Mitogen-activated protein kinase 6 (MAPK6), also known as extracellular signal-regulated kinase 3 (ERK3), is an atypical member of the MAPK family characterized by a 100 kDa molecular mass, 721 amino acids, a typical N-terminal kinase domain, and an extended C-terminal region that shares significant similarity with ERK4. Unlike classical MAPKs, MAPK6 lacks the Thr-X-Tyr motif in its activation loop and instead has a single phospho-acceptor site (Ser-Glu-Gly). Depending on the literature source, MAPK6\/ERK3 may also be discussed as MAPK6\/ERK3.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following MAPK6\/ERK3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eMAPK6\/ERK3 is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm and nucleus across matched conditions\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MAPK6\/ERK3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MAPK6\/ERK3 reflect biology rather than handling. When interpreting MAPK6\/ERK3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep MAPK6\/ERK3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577864266073,"sku":"F2109-20UL","price":95.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577864298841,"sku":"F2109-100UL","price":289.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577864331609,"sku":"F2109-2X100UL","price":459.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2109-wb.gif?v=1773600181","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/mapk6-erk3-antibody-sc-f2109","provider":"Absource Diagnostics","version":"1.0","type":"link"}